Qualitative plasma PCR assay (AMPLICOR CMV test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic stem cell transplantation.
about
A prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 antigenemia assay in monitoring patients after allogeneic stem cell transplantationImproved monitoring of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation by an ultrasensitive plasma DNA PCR assay.Prevention of cytomegalovirus disease in recipients of allogeneic stem cell transplantsQuantification of DNA in plasma by an automated real-time PCR assay (cytomegalovirus PCR kit) for surveillance of active cytomegalovirus infection and guidance of preemptive therapy for allogeneic hematopoietic stem cell transplant recipients.Cytomegalovirus infection in hematologic malignancy settings other than the allogeneic transplant.IL28B genetic variation and cytomegalovirus-specific T-cell immunity in allogeneic stem cell transplant recipients.Timing of CMV-specific effector memory T cells predicts viral replication and survival after allogeneic hematopoietic stem cell transplantation.Cytomegalovirus infection and disease after reduced intensity conditioning allogeneic stem cell transplantation: single-centre experience.Comparison of two commercially available pp65 antigenemia tests and COBAS Amplicor CMV Monitor for early detection and quantification of episodes of human CMV-viremia in transplant recipients.Reconstitution of lymphocyte populations and cytomegalovirus viremia or disease after allogeneic peripheral blood stem cell transplantation.Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipientsComparison of the Commercial QuantiFERON-CMV and Overlapping Peptide-based ELISPOT Assays for Predicting CMV Infection in Kidney Transplant Recipients.Algorithm based on CMV kinetics DNA viral load for preemptive therapy initiation after hematopoietic cell transplantation.
P2860
Q33264234-4AA3B42D-BB31-40B3-B6B5-F67AEF5CF60CQ34437840-2675CD4C-B4E8-4644-935D-32F8D65BCE45Q35558815-F5CC03C7-246E-4F89-81C2-FD36BBB72829Q36933563-9E98CF18-2405-4BE3-ADC8-C3346CA756C4Q38703120-8C2C9152-8B6F-4B98-AA62-249E04FC33BBQ39425526-607381A9-6590-4C59-A7C5-F7FA958EED2AQ42203312-9FBD396D-8772-4437-8CC1-A2224746E647Q43294885-ECD1973A-23E8-4518-A96D-E933D586439EQ43413495-F3B7979A-1705-4C12-AC75-7CAED711CDA3Q44453947-E5326024-F610-474B-AB1E-7C0D0871A8B4Q45925385-90553FE2-57C7-4E92-B09D-1E9928C8A77DQ47134886-75068F0C-CAFF-4392-9512-EE7B8EF5705EQ51609961-D6282EF6-57FA-4329-B918-338558E28B28
P2860
Qualitative plasma PCR assay (AMPLICOR CMV test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic stem cell transplantation.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Qualitative plasma PCR assay ( ...... eic stem cell transplantation.
@en
Qualitative plasma PCR assay
@nl
type
label
Qualitative plasma PCR assay ( ...... eic stem cell transplantation.
@en
Qualitative plasma PCR assay
@nl
prefLabel
Qualitative plasma PCR assay ( ...... eic stem cell transplantation.
@en
Qualitative plasma PCR assay
@nl
P2093
P2860
P1476
Qualitative plasma PCR assay ( ...... eic stem cell transplantation.
@en
P2093
A Gutiérrez
J García-Conde
P2860
P304
P356
10.1128/JCM.39.11.3938-3941.2001
P407
P577
2001-11-01T00:00:00Z